INTRODUCTION
Statistical evaluation of clinical pathology data of preclinical toxicological studies is the final stage culminating in a large investment in time, money, and animals. Standards have been laid down by the Good Laboratory Practice regulations to upgrade the quality of the data generated (10) . Little attention, however, has been given to the critical stage of statistical analysis and, consequently, data evaluation (12) . Although the various guidelines (9) suggest that statistical tests be used to evaluate the data generated from toxicological studies, no (6, 14) . This should be considered a severe drawback in the statistical evaluation because it is reported that skewness of distribution may produce too many significant results in the ANOVA and t-tests (7 (3, 4, 8) .
In conclusion, no standard statistical procedures are at present being used to analyze clinical pathological data. There are some common approaches to the problem; however, glaring differences and irregularities do exist. In some cases, the approach to the evaluation sheds doubt on the validity of the method of statistical analysis and, as a result, must put the interpretation of the results of the data in question.
